Drug · DIN 02252007
PMS-RISPERIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 5, 2006; first marketed July 5, 2006.
- Drug Identification Number (DIN)
- 02252007
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 5, 2006: NOC 8121Abbreviated New Drug Submission (ANDS)
Other DINs named PMS-RISPERIDONE
- DIN 02252015 · Marketed
- DIN 02252023 · Marketed
- DIN 02252031 · Marketed
- DIN 02252058 · Marketed
- DIN 02252066 · Marketed
- DIN 02279266 · Marketed